Rockefeller Capital Management L.P. Has $1.54 Million Position in The Cooper Companies, Inc. $COO

Rockefeller Capital Management L.P. increased its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 156.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 18,855 shares of the medical device company’s stock after acquiring an additional 11,503 shares during the quarter. Rockefeller Capital Management L.P.’s holdings in Cooper Companies were worth $1,545,000 at the end of the most recent quarter.

A number of other large investors have also bought and sold shares of COO. Larry Mathis Financial Planning LLC bought a new position in shares of Cooper Companies during the 4th quarter worth about $489,000. River Road Asset Management LLC increased its position in Cooper Companies by 1.0% in the 4th quarter. River Road Asset Management LLC now owns 1,582,867 shares of the medical device company’s stock valued at $129,732,000 after buying an additional 16,103 shares in the last quarter. Kera Capital Partners Inc. acquired a new position in Cooper Companies during the 4th quarter worth approximately $216,000. Axxcess Wealth Management LLC raised its stake in Cooper Companies by 37.1% during the 4th quarter. Axxcess Wealth Management LLC now owns 9,980 shares of the medical device company’s stock worth $818,000 after buying an additional 2,698 shares during the period. Finally, Corient Private Wealth LLC boosted its holdings in Cooper Companies by 17.0% in the fourth quarter. Corient Private Wealth LLC now owns 25,699 shares of the medical device company’s stock worth $2,106,000 after acquiring an additional 3,738 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Stock Performance

Shares of Cooper Companies stock opened at $71.71 on Wednesday. The company has a market cap of $13.99 billion, a PE ratio of 60.77, a price-to-earnings-growth ratio of 1.87 and a beta of 0.87. The Cooper Companies, Inc. has a 52 week low of $58.89 and a 52 week high of $89.83. The business has a 50 day moving average price of $64.18 and a 200-day moving average price of $73.50. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The company had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. During the same quarter last year, the company earned $0.96 earnings per share. The company’s revenue for the quarter was up 7.9% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities analysts anticipate that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on COO. BNP Paribas Exane reduced their price objective on Cooper Companies from $95.00 to $92.00 and set an “outperform” rating for the company in a research note on Monday, June 8th. JPMorgan Chase & Co. cut their target price on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating on the stock in a report on Friday, June 5th. Needham & Company LLC reduced their price target on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a research report on Friday, June 5th. Barclays boosted their price target on shares of Cooper Companies from $98.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday, March 6th. Finally, Wells Fargo & Company restated a “sell” rating and set a $66.00 price objective (down from $82.00) on shares of Cooper Companies in a report on Friday, June 5th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have given a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, Cooper Companies currently has a consensus rating of “Hold” and a consensus target price of $81.31.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.